Avory & Company’s Nutanix NTNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,099
Closed -$367K 46
2025
Q4
$367K Buy
+7,099
New +$434K 0.23% 26
2025
Q1
Sell
-129,038
Closed -$7.89M 32
2024
Q4
$7.89M Sell
129,038
-3,976
-3% -$260K 4.42% 10
2024
Q3
$7.88M Sell
133,014
-7,011
-5% -$385K 4.78% 9
2024
Q2
$7.96M Sell
140,025
-34,115
-20% -$2.09M 5.6% 8
2024
Q1
$10.7M Sell
174,140
-228,656
-57% -$13.2M 7.32% 6
2023
Q4
$19.2M Sell
402,796
-43,330
-10% -$1.75M 13.44% 3
2023
Q3
$15.6M Sell
446,126
-113,748
-20% -$3.57M 13.21% 3
2023
Q2
$15.7M Sell
559,874
-36,277
-6% -$963K 11.96% 1
2023
Q1
$15.5M Sell
596,151
-120,462
-17% -$3.26M 10.66% 2
2022
Q4
$18.7M Sell
716,613
-47,614
-6% -$1.3M 15.01% 2
2022
Q3
$15.9M Buy
764,227
+58,734
+8% +$1.07M 13.49% 1
2022
Q2
$10.3M Buy
705,493
+12,798
+2% +$267K 8.76% 4
2022
Q1
$18.6M Buy
692,695
+40,945
+6% +$1.1M 11.63% 3
2021
Q4
$17.9M Buy
651,750
+105,922
+19% +$3.63M 10.75% 3
2021
Q3
$20.6M Sell
545,828
-133,620
-20% -$5.05M 12.71% 2
2021
Q2
$26M Buy
679,448
+14,539
+2% +$453K 14.43% 2
2021
Q1
$17.7M Buy
664,909
+156,860
+31% +$4.77M 10.17% 4
2020
Q4
$16.2M Buy
+508,049
New +$13.8M 10.88% 3

Other funds holding NTNX

Avory & Company's NTNX Position: Q1 2026 in Review

Avory & Company sold out of Nutanix (NTNX) in Q1 2026, closing a stake of 7,099 shares — an estimated $367K sold.

Avory & Company first reported a position in NTNX in Q4 2020 and held it in 18 quarters. The position peaked at $26M in Q2 2021. 538 funds tracked by Wall St. Rank hold NTNX as of Q1 2026.

  • Avory & Company reported no remaining Nutanix position as of Q1 2026 after selling out during the quarter.
  • Avory & Company sold 7,099 Nutanix shares in Q1 2026, an estimated $367K.
  • Avory & Company first reported a position in Nutanix in Q4 2020 and held it in 18 quarters.
  • Avory & Company's Nutanix position peaked at $26M in Q2 2021.
  • 538 funds tracked by Wall St. Rank held Nutanix as of Q1 2026.

Based on Avory & Company's 13F filing for Q1 2026, filed 29 Apr 2026.